Best Benjamin P
Life Extension Foundation , Coconut Creek, Florida.
Rejuvenation Res. 2015 Oct;18(5):422-36. doi: 10.1089/rej.2014.1656. Epub 2015 Sep 22.
High levels of penetrating cryoprotectants (CPAs) can eliminate ice formation during cryopreservation of cells, tissues, and organs to cryogenic temperatures. But CPAs become increasingly toxic as concentration increases. Many strategies have been attempted to overcome the problem of eliminating ice while minimizing toxicity, such as attempting to optimize cooling and warming rates, or attempting to optimize time of adding individual CPAs during cooling. Because strategies currently used are not adequate, CPA toxicity remains the greatest obstacle to cryopreservation. CPA toxicity stands in the way of cryogenic cryopreservation of human organs, a procedure that has the potential to save many lives. This review attempts to describe what is known about CPA toxicity, theories of CPA toxicity, and strategies to reduce CPA toxicity. Critical analysis and suggestions are also included.
高浓度的渗透性冷冻保护剂(CPA)可在细胞、组织和器官冷冻保存至低温时消除冰晶形成。但随着浓度增加,CPA的毒性也会越来越大。人们尝试了许多策略来克服消除冰晶同时将毒性降至最低的问题,比如试图优化降温与升温速率,或者试图优化降温过程中添加单个CPA的时间。由于目前使用的策略并不充分,CPA毒性仍然是冷冻保存面临的最大障碍。CPA毒性阻碍了人体器官的低温冷冻保存,而这一过程有可能挽救许多生命。本综述试图描述关于CPA毒性的已知信息、CPA毒性理论以及降低CPA毒性的策略。还包括批判性分析和建议。